Abstract
Patients with chronic kidney disease (CKD) are at high risk for development or reactivation of tuberculosis (TB). To identify latent TB infection, Mantoux test (MT)/tuberculin skin test (TST) is widely used in Bangladesh because of its low cost. However, in CKD patients, the sensitivity of this test is questioned. In this study we compared the reactivity of MT in people with different CKD stages. We also compared the reactivity of MT with IGRA (interferon gamma release assay) in CKD patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
